z-logo
Premium
New perspectives regarding β 2 ‐adrenoceptor ligands in the treatment of asthma
Author(s) -
Walker JKL,
Penn RB,
Hanania NA,
Dickey BF,
Bond RA
Publication year - 2011
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.2010.01178.x
Subject(s) - g protein coupled receptor , receptor , signalling , relevance (law) , signal transduction , drug discovery , ligand (biochemistry) , neuroscience , computational biology , functional selectivity , biology , chemistry , pharmacology , bioinformatics , microbiology and biotechnology , biochemistry , political science , law
In the last two decades several significant changes have been proposed in the receptor theory that describes how ligands can interact with G protein-coupled receptors (GPCRs). Here we briefly summarize the evolution of receptor theory and detail recent prominent advances. These include: (i) the existence of spontaneously active GPCRs that are capable of signalling even though they are unoccupied by any ligand; (ii) the discovery of ligands that can inactivate these spontaneously active receptors; (iii) the notion that a ligand may simultaneously activate more than one GPCR signalling pathway; and (iv) the notion that certain ligands may be able to preferentially direct receptor signalling to a specific pathway. Because the data supporting these receptor theory ideas are derived primarily from studies using artificial expression systems, the physiological relevance of these new paradigms remains in question. As a potential example of how these new perspectives in receptor theory relate to drug actions and clinical outcomes, we discuss their relevance to the recent controversy regarding the chronic use of β(2) -adrenoceptor agonists in the treatment of asthma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here